Table 5.
Active PWID Subanalysis
| Active PWID (n = 109) | Value |
|---|---|
| SVR, n (%) | 92 (84) |
| Non-SVR, n (%) | 17 (16) |
| Reason for non-SVR | |
| LTFU (% of all LTFU) | 9 (70) |
| D/C (% of all D/C) | 2 (100) |
| Relapse (% of all relapse) | 6 (86) |
| LTFU in active PWID (n = 9) | |
| Pre-EOT LTFU, n (%) | 4 (44) |
| Post-EOT LTFU, n (%) | 5 (66) |
| Undetectable HCV RNA at EOT, n (%) | 5 (100) |
| mITT SVR in active PWID, % | 88 |
| P value (vs mITT in nonactive PWID) | .1157 |
| Injection during treatment, n (%) | 8 (89) |
Abbreviations: active PWID, injected drugs in past 6 months; D/C, discontinuation; EOT, end of treatment; ITT, intent-to-treat; LTFU, lost to follow-up; mITT, modified intent-to-treat; OST, opiate substitution therapy; PWID, people who inject drugs; SVR, sustained virological response.